Evidence map›Paper›PMID 28069248›Full record

Trial reportThe Journal of allergy and clinical immunology2017

Race is associated with differences in airway inflammation in patients with asthma.

Sharmilee M Nyenhuis, Jerry A Krishnan, Alalia Berry, William J Calhoun, Vernon M Chinchilli, Linda Engle, Nicole Grossman, Fernando Holguin, Elliot Israel, Rick A Kittles and 14 more

Registry-linked trialAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in The Journal of allergy and clinical immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05246267 (Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis), which is not on this map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05246267 recruitingnot on this mapstarted 2022, after this paper: background citation

Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)

TypeobservationalSponsorMontefiore Medical CenterRan2022 to 2026Enrolled60ConditionsChronic Rhinosinusitis With Nasal PolypsArmsDupilumab
3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER).Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2020
    Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Upper Airway Volume Predicts Brain Structure and Cognition in Adolescents.American journal of respiratory and critical care medicine · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Viral and non-viral episodes of wheezing in early life and the development of asthma and respiratory phenotypes among urban children.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2024
    Article
  12. Article
  13. Asthma morbidity measures across Black ethnic subgroups.The Journal of allergy and clinical immunology · 2024
    Article
  14. Questions in Mild Asthma: An Official American Thoracic Society Research Statement.American journal of respiratory and critical care medicine · 2023
    Article
  15. Article
  16. An Overview of Health Disparities in Asthma.The Yale journal of biology and medicine · 2021
    Review
  17. Article
  18. Characteristics of inflammatory phenotypes among patients with asthma: relationships of blood count parameters with sputum cellular phenotypes.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Sharmilee M NyenhuisDepartment of Medicine, University of Illinois at Chicago, Chicago, Ill; University of Illinois Hospital & Health Sciences System, Chicago, Ill. Electronic address: snyenhui@uic.edu.
Jerry A KrishnanDepartment of Medicine, University of Illinois at Chicago, Chicago, Ill; University of Illinois Hospital & Health Sciences System, Chicago, Ill.
Alalia BerryDivision of Allergy, Pulmonary and Critical Care, Department of Medicine, the University of Wisconsin School of Medicine and Public Health, University of Wisconsin, Madison, Wis.
William J CalhounDivision of Pulmonary Critical Care & Sleep Medicine, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Tex.
Vernon M ChinchilliDepartment of Public Health Sciences, Pennsylvania State University, Hershey, Pa.
Linda EngleDepartment of Public Health Sciences, Pennsylvania State University, Hershey, Pa.
Nicole GrossmanPulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Mass.
Fernando HolguinDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pa.
Elliot IsraelPulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Mass.
Rick A KittlesUniversity of Arizona College of Medicine, Tucson, Ariz.
Monica KraftUniversity of Arizona College of Medicine, Tucson, Ariz.
Stephen C LazarusDivision of Pulmonary and Critical Care, Department of Medicine, University of California, San Francisco, Calif.
Erik B LehmanDepartment of Public Health Sciences, Pennsylvania State University, Hershey, Pa.
David T MaugerDepartment of Public Health Sciences, Pennsylvania State University, Hershey, Pa.
James N MoyStroger Hospital of Cook County, Chicago, Ill.
Stephen P PetersDivision of Pulmonary, Critical Care, Allergy and Immunologic Diseases, Department of Medicine, Wake Forest School of Medicine, Winston-Salem, NC.
Wanda PhipatanakulDivision of Allergy and Immunology, Department of Pediatrics, Boston Children's Hospital, Boston, Mass.
Lewis J SmithDivision of Pulmonary and Critical Care, Department of Medicine Northwestern University, Feinberg School of Medicine, Chicago, Ill.
Kaharu SuminoDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St Louis, Mo.
Stanley J SzeflerDivision of Pulmonary Medicine, Department of Pediatrics, Children's Hospital of Colorado, Aurora, Colo.
Michael E WechslerPulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Mass; Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, Colo.
Sally WenzelDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pa.
Steven R WhiteDivision of Pulmonary/Critical Care, Department of Medicine, University of Chicago, Chicago, Ill.
Steven J AckermanDepartment of Medicine, University of Illinois at Chicago, Chicago, Ill.

Funding

Data Coordinating Center for the NHLBI Asthma Network (AsthmaNet)U10HL098115 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI MAUGER, DAVID T. · 2009 to 2015
$57.6M
Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
PEDIATRIC ASTHMA NETWORK DATA COORDINATING CENTERU10HL064313 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI MAUGER, DAVID T. · 1999 to 2008
$18.3M
ACRN Data Coordinating CenterU10HL074231 · NHLBI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI CHINCHILLI, VERNON M. · 2003 to 2007
$13.3M
Center for Clinical and Translational ScienceUL1TR000050 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI AZAR, DIMITRI T, MERMELSTEIN, ROBIN J. · 2012 to 2014
$9.8M
Informative Clinical Studies in AsthmaU10HL074227 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ISRAEL, ELLIOT · 2003 to 2007
$5.8M
AsthmaNet: Brigham and Women's Hospital & Children's Hospital BostonU10HL098102 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI ISRAEL, ELLIOT, PHIPATANAKUL, WANDA · 2009 to 2015
$5.5M
Clinical Centers for the NHLBI Asthma Network (AsthmaNet)U10HL098075 · NHLBI · NATIONAL JEWISH HEALTH · PI SZEFLER, STANLEY J., WECHSLER, MICHAEL E · 2009 to 2015
$5.1M
Treatment of Severe Persistent AsthmaU10HL074212 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI LEMANSKE, ROBERT F · 2003 to 2007
$4.9M
AsthmaNet: UW-Madison Clinical and Translational Research CenterU10HL098090 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI LEMANSKE, ROBERT F, SORKNESS, CHRISTINE ANNE · 2009 to 2015
$4.8M
UCSF AsthmaNet Clinical CenterU10HL098107 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CABANA, MICHAEL D, LAZARUS, STEPHEN C · 2009 to 2015
$4.8M
Chicagoland Metropolitan AsthmaNet Consortium (CMAC)U10HL098096 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KRISHNAN, JERRY A., PONGRACIC, JACQUELINE · 2009 to 2015
$4.6M
NCATS NIH HHS UL1 TR000050NCATS NIH HHS UL1 TR001422NCRR NIH HHS KL2 RR029878NHLBI NIH HHS R21 HL118588NHLBI NIH HHS U10 HL064313NHLBI NIH HHS U10 HL074073NHLBI NIH HHS U10 HL074204NHLBI NIH HHS U10 HL074206NHLBI NIH HHS U10 HL074208NHLBI NIH HHS U10 HL074212NHLBI NIH HHS U10 HL074218NHLBI NIH HHS U10 HL074225NHLBI NIH HHS U10 HL074227NHLBI NIH HHS U10 HL074231NHLBI NIH HHS U10 HL098075NHLBI NIH HHS U10 HL098090NHLBI NIH HHS U10 HL098096NHLBI NIH HHS U10 HL098098NHLBI NIH HHS U10 HL098102NHLBI NIH HHS U10 HL098103NHLBI NIH HHS U10 HL098107NHLBI NIH HHS U10 HL098115
6 · The paper itself

Abstract

backgroundAfrican American subjects have a greater burden from asthma compared with white subjects. Whether the pattern of airway inflammation differs between African American and white subjects is unclear.

objectiveWe sought to compare sputum airway inflammatory phenotypes of African American and white subjects treated or not with inhaled corticosteroids (ICSs; ICS+ and ICS-, respectively).

methodsWe performed a secondary analysis of self-identified African American and white subjects with asthma enrolled in clinical trials conducted by the National Heart, Lung, and Blood Institute-sponsored Asthma Clinical Research Network and AsthmaNet. Demographics, clinical characteristics, and sputum cytology after sputum induction were examined. We used a sputum eosinophil 2% cut point to define subjects with either an eosinophilic (≥2%) or noneosinophilic (<2%) inflammatory phenotype.

resultsAmong 1018 participants, African American subjects (n = 264) had a lower FEV

conclusionAfrican American subjects exhibit greater eosinophilic airway inflammation, which might explain the greater asthma burden in this population.

Indexed as

Black PeopleWhite PeopleAdrenal Cortex HormonesAdultAsthmaBlack or African AmericanEosinophiliaFemaleForced Expiratory VolumeHumansImmunoglobulin ELeukocyte CountMaleMiddle AgedNeutrophilsPhenotypeAdrenal Cortex HormonesImmunoglobulin EAfrican Americanairway inflammationAsthmabody mass indexclinical trialcorticosteroideosinophilinduced sputumrace

Identifiers

PMID28069248
PMCPMC5494010

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.